Am J Transplant, Volume 22, Suppl 3 Archives - Page 61 of 190 - ATC Abstracts

2022 American Transplant Congress
The Cost And Logistical Challenges To Kidney Paired Donation
S. G. Yi¹, V. E. Whittaker², T. B. Dunn³, N. Goldaracena⁴, V. Humphreville⁵, C. Kubal⁶, C. Kuhr⁷, D. Leeser⁸, J. Pomposelli⁹, E. Thomas¹⁰, N. Turgeon¹¹, C. Varma¹², M. Rees¹³, A. K. Mathur¹⁴
¹Houston Methodist Hospital, Houston, TX, ²New York Medical College, Scarsdale, NY, ³University of Pennsylvania, Philadelphia, PA, ⁴Transplant Surgery, University of Virginia Health System, Charlottesville, VA, ⁵University of Minnesota Medical Center, Minneapolis, MN, ⁶Indiana University Hospital, Indianapolis, IN, ⁷Virgina Mason Medical Center, Seattle, WA, ⁸East Carolina Univ Sch of Med, Greenville, NC, ⁹University of Colorado, Aurora, CO, ¹⁰University of Texas Health Science Center at San Antonio, San Antonio, TX, ¹¹Dell Seton Medical Center at The University of Texas, Austin, TX, ¹²St Louis University Hospital, St Louis, MO, ¹³University of Toledo Medical Center, Toledo, OH, ¹⁴Mayo Clinic in Arizona, Phoenix, AZ
*Purpose: Kidney paired donation (KPD) is a strategy for finding compatible pairing for living kidney transplantation (LDKT); however, only a small portion of LDKT continues…
2022 American Transplant Congress
Allocation Based on Acuity Circles Decreases Waiting Time for Liver Transplant Patients
M. H. Kim, K. Sasaki, A. Gallo, T. Pham, M. L. Melcher, S. Busque, C. Esquivel, C. Bonham
Stanford University, Stanford, CA
*Purpose: In February, 2020, UNOS implemented a new liver allocation system incorporating a combination of acuity based on MELD/PELD score and distance from the donor…
2022 American Transplant Congress
Accepting Rejection in Liver Transplant Recipients Requiring Renal Replacement Therapy: A Practice Paradigm
S. Farghaly¹, T. Sparkes¹, B. Masters¹, A. Haririan², N. Jakhete³, R. N. Barth⁴, D. Maluf⁵, S. Freedman¹
¹Pharmacy, University of Maryland Medical Center, Baltimore, MD, ²Nephrology, University of Maryland Medical Center, Baltimore, MD, ³Hepatology, University of Maryland Medical Center, Baltimore, MD, ⁴Transplant Surgery, University of Chicago Medical Center, Chicago, IL, ⁵Transplant Surgery, University of Maryland Medical Center, Baltimore, MD
*Purpose: The purpose of this study is to evaluate rejection outcomes in those requiring renal replacement therapy (RRT) after liver transplant.*Methods: This was a single…
2022 American Transplant Congress
Clinical Relevance of Class II HLA Mismatches in Living Donor Kidney Transplantation
J. Lan¹, M. Kadatz¹, D. Chang¹, R. Liwski², E. Wagner², P. Campbell², J. Gill¹, J. Gill¹
¹University of British Columbia, Vancouver, BC, Canada, ²On behalf of Canadian HLA Advisory Committee, Ottawa, ON, Canada
*Purpose: The benefit of class II HLA matching is primarily shown in deceased donor kidney transplantation. The objective of this study was to determine the…
2022 American Transplant Congress
Outcomes of Post-Operative Plasmapheresis in African American Kidney Transplant Recipients with High Panel Reactive Antibodies – A Single Center Experience
B. Valdepenas, M. Campara, J. Benken, C. Muran, D. Pierce, K. Heagler, P. DiCocco, J. Almario Alvarez, M. Spaggiari, I. Tang, I. Tzvetanov, E. Benedetti
University of Illinois at Chicago, Chicago, IL
*Purpose: African American (AA) kidney transplant (KTx) candidates are disadvantaged given increased immunologic risk and longer waitlist time. The purpose of this study was to…
2022 American Transplant Congress
Evaluation of Prophylactic Valganciclovir Dosing in Kidney Transplant Recipients at an Urban Transplant Institution
E. Foster¹, D. Pierce¹, T. Cairns¹, S. Borgetti², I. Tzvetanov³, E. Benedetti³, C. Muran¹
¹Pharmacy, University of Illinois at Chicago, Chicago, IL, ²Medicine, University of Illinois at Chicago, Chicago, IL, ³Surgery, University of Illinois at Chicago, Chicago, IL
*Purpose: Dosing and duration of cytomegalovirus (CMV) prophylaxis with valganciclovir (VGC) in kidney transplant (KT) recipients is variable by transplant center. Prior studies have shown…
2022 American Transplant Congress
Assessment of Pain Management Regimens After Living Donor Nephrectomy
M. Lebin¹, B. Crowther², K. Klingenberg², V. Lewis², K. Moller², H. Moore², K. Way², C. Lyda², A. Howell², R. Cooke³, P. Klem²
¹University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, ²University of Colorado Hospital, Aurora, CO, ³Boulder Community Hospital, Boulder, CO
*Purpose: Opioid sparing pain control protocols are widely accepted within health systems nationwide. In living donor kidney transplantation, pain control is addressed in a multimodal…
2022 American Transplant Congress
The Oncological Influences of Pre- and Post-Transplant Sustained Viral Response in Liver Transplant for Hepatocellular Carcinoma
K. Sasaki¹, S. Kimura², K. Tomiyama³, Y. Bekki⁴, M. Murray³, P. Huang³, M. Fruscione², A. Moro⁵, C. Kwon⁶
¹Stanford University, Stanford, CA, ²Massachusetts General Hospital, Boston, MA, ³University of Rochester, Rochester, NY, ⁴Mount Sinai Medical Center, New York, NY, ⁵University of South Florida, Tampa, FL, ⁶Cleveland Clinic, Cleveland, OH
*Purpose: Chronic hepatitis C infection (HCV) is one of the most common causes of hepatocellular carcinoma. After emerging direct-acting agents (DAA), the success rate of…
2022 American Transplant Congress
Perfusate Cell-Free DNA Content is a Potential Marker of Cellular Injury During Hypothermic Machine Perfusion of Porcine Kidneys Subject to Prolonged Warm Ischemia
V. Boominathan¹, M. Willman¹, N. Battula², A. Zarrinpar¹, S. Duarte¹
¹University of Florida, Gainesville, FL, ²University of Oklahoma, Oklahoma City, OK
*Purpose: Despite the potential benefits and expanding use of advanced dynamic perfusion systems in clinical practice, to date there is no robust and non-invasive method…
2022 American Transplant Congress
Holes in the Safety-Net: Examining the Path to Kidney Transplantation for Liver Transplant Recipients with Persistent Kidney Dysfunction
A. J. Erhardt, M. J. Hobeika, T. Menser, A. Saharia, O. Okidi, C. Mobley, R. McMillan, L. W. Moore, H. Podder, S. Yi, R. J. Knight, A. Gaber, R. Ghobrial
Department of Surgery; J.C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX
*Purpose: The 2017 combined liver-kidney allocation modification provided early access to kidney transplantation (KT) for liver transplant (LT) recipients with severe post-LT kidney dysfunction. Although…